AML Classifier for WHO 2022 and ICC 2022

Haem.io provides explainable AML classification support for genomic-era hematology workflows. The platform is built to execute complex guideline logic consistently, with transparent evidence trails and risk outputs aligned to ELN guidance.

Current production focus is AML and MDS pathways. Teams can review deterministic outputs, compare WHO and ICC framing, and inspect the criteria path behind each classification support output.

What this page targets

Acute myeloid leukemia classification support
AML classification with WHO 2022 and ICC 2022 criteria
Explainable clinical decision support in hematology

Try the interactive classifier Leukemia decision support overview Read related articles